KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Treasury Shares: 2010-2024

Historic Treasury Shares for Nektar Therapeutics (NKTR) over the last 12 years, with Dec 2024 value amounting to $552,307.

  • Nektar Therapeutics' Treasury Shares changed negligibly% to $3.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $3.0 million for FY2024, which is N/A change from last year.
  • Nektar Therapeutics' Treasury Shares amounted to $3.0 million in FY2024.
  • Nektar Therapeutics' Treasury Shares' 5-year high stood at $3.0 million during FY2024, with a 5-year trough of $3.0 million in FY2024.
  • Moreover, its 2-year median value for Treasury Shares was $4.9 million (2022), whereas its average is $4.9 million.
  • Its Treasury Shares has fluctuated over the past 5 years, first skyrocketed by 43.75% in 2020, then decreased by 6.22% in 2022.
  • Nektar Therapeutics' Treasury Shares (Yearly) stood at $7.1 million in 2020, then soared by 39.98% to $9.9 million in 2021, then declined by 6.22% to $9.3 million in 2022, then reached $552,307 in 2024.